These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23013091)

  • 1. Protocols, physiology, and trials of hydroxyethyl starch.
    Wise R; Fourie C; Richards GA
    N Engl J Med; 2012 Sep; 367(13):1266-7; author reply 1267. PubMed ID: 23013091
    [No Abstract]   [Full Text] [Related]  

  • 2. Protocols, physiology, and trials of hydroxyethyl starch.
    Chappell D; Jacob M
    N Engl J Med; 2012 Sep; 367(13):1266; author reply 1267. PubMed ID: 23013090
    [No Abstract]   [Full Text] [Related]  

  • 3. Protocols, physiology, and trials of hydroxyethyl starch.
    von Heymann C; Sander M; Spies CD
    N Engl J Med; 2012 Sep; 367(13):1265-6; author reply 1267. PubMed ID: 23013089
    [No Abstract]   [Full Text] [Related]  

  • 4. Protocols, physiology, and trials of hydroxyethyl starch.
    Magder S
    N Engl J Med; 2012 Sep; 367(13):1265; author reply 1267. PubMed ID: 23013088
    [No Abstract]   [Full Text] [Related]  

  • 5. Is it the end of the road for synthetic starches in critical illness? No place for hydroxyethyl starch solutions in treatment of patients with sepsis.
    Prowle JR; Pearse RM
    BMJ; 2013 Mar; 346():f1805. PubMed ID: 23516156
    [No Abstract]   [Full Text] [Related]  

  • 6. Hydroxyethyl starch 130/0.42 for bolus resuscitation in severe sepsis: long-term follow-up, confidence intervals and clinically important differences in outcomes.
    Doig GS; Simpson F
    Intensive Care Med; 2014 Jul; 40(7):1036-8. PubMed ID: 24841701
    [No Abstract]   [Full Text] [Related]  

  • 7. Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis.
    Haase N; Perner A; Hennings LI; Siegemund M; Lauridsen B; Wetterslev M; Wetterslev J
    BMJ; 2013 Feb; 346():f839. PubMed ID: 23418281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantity may be more important than type of intravenous fluid.
    Silversides JA; Ferguson AJ
    Crit Care Med; 2012 Feb; 40(2):709-10; author reply 710-1. PubMed ID: 22249072
    [No Abstract]   [Full Text] [Related]  

  • 9. Colloids and renal dysfunction: another brick in the wall of safety concerns.
    Erstad BL
    Crit Care Med; 2011 Jun; 39(6):1565-6. PubMed ID: 21610625
    [No Abstract]   [Full Text] [Related]  

  • 10. Hydroxyethyl starch in sepsis.
    Haase NR
    Dan Med J; 2014 Jan; 61(1):B4764. PubMed ID: 24393593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal morbidity as primary outcome measure in studies comparing crystalloid and colloid within a goal-directed therapy.
    Hunsicker O; Scott MJ; Miller TE; Baldini G; Feldheiser A
    Br J Anaesth; 2015 Jan; 114(1):160-2. PubMed ID: 25500398
    [No Abstract]   [Full Text] [Related]  

  • 12. Gastrointestinal morbidity as primary outcome measure in studies comparing crystalloid and colloid within a goal-directed therapy.
    Hunsicker O; Scott MJ; Miller TE; Baldini G; Feldheiser A
    Br J Anaesth; 2015 Jul; 115(1):128-9. PubMed ID: 26089448
    [No Abstract]   [Full Text] [Related]  

  • 13. Tetrastarch for fluid resuscitation in septic shock: good news for the kidneys?
    Matsusaki T; Morimatsu H
    Crit Care Med; 2011 Apr; 39(4):905-6. PubMed ID: 21613848
    [No Abstract]   [Full Text] [Related]  

  • 14. Colloid versus crystalloid fluid therapy in surgical patients.
    Arunachalam L; MacFie J
    Br J Surg; 2015 Feb; 102(3):145-7. PubMed ID: 25533178
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute kidney injury with hydroxyethyl starch 130/0.42 in severe sepsis.
    Müller RB; Haase N; Lange T; Wetterslev J; Perner A
    Acta Anaesthesiol Scand; 2015 Mar; 59(3):329-36. PubMed ID: 25524831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged Field Care Working Group Fluid Therapy Recommendations.
    Baker BL; Powell D; Riesberg J; Keenan S
    J Spec Oper Med; 2016; 16(1):112-7. PubMed ID: 27045508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of Hospital and Patient Characteristics with Fluid Resuscitation Volumes in Patients with Severe Sepsis: Post Hoc Analyses of Data from a Multicentre Randomised Clinical Trial.
    Hjortrup PB; Haase N; Wetterslev J; Perner A
    PLoS One; 2016; 11(5):e0155767. PubMed ID: 27196104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Choice of Fluids in Severe Septic Patients - A Cost-effectiveness Analysis Informed by Recent Clinical Trials.
    Farrugia A; Bansal M; Balboni S; Kimber MC; Martin GS; Cassar J
    Rev Recent Clin Trials; 2014; 9(1):21-30. PubMed ID: 24330133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is 6% tetrastarch 130kDa (hydroxyethyl starch 130/0.4 or 130/0.42) suitable for severe sepsis?
    Patel A; Brett SJ
    Br J Hosp Med (Lond); 2013 Mar; 74(3):178. PubMed ID: 23665793
    [No Abstract]   [Full Text] [Related]  

  • 20. Fluid solutions in dengue shock syndrome.
    Goel A; Thabah MM
    N Engl J Med; 2005 Dec; 353(23):2510-1; author reply 2510-1. PubMed ID: 16353299
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.